Anti-MRSA agent 14

• UNSPSC Description:

  Anti-MRSA agent 14 (Compound C17) has antibacterial agent against MRSA and MRSA-infected skin murine model. Anti-MRSA agent 14 is more potential than Norfloxacin (HY-B0132) against MRSA. Anti-MRSA agent 14 disrupts cell membrane and restrains metabolism. Anti-MRSA agent 14 shows antibacterial effects against S. aureus ATCC 6538, S. aureus ATCC 29213, S. epidermidis ATCC 12228, and MRSA with MIC values of 1, 2, 2, 1 μM respectively[1].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/anti-mrsa-agent-14.html

• Smiles:

  CC1(C)CC[C@]2(C(NS(C3=CC=C(Cl)C=C3)(=O)=O)=O)CC[C@@]4(C)[C@]5(C)CC[C@@]6([H])C(C)(C)C7=C(C(C=CC=C8C(O)=O)=C8N7)C[C@]6(C)[C@@]5([H])CC=C4[C@]2([H])C1

• Molecular Weight:

  745.41

• References & Citations:

  [1]Li J, et al. Design and synthesis of unique indole-benzosulfonamide oleanolic acid derivatives as potent antibacterial agents against MRSA. Eur J Med Chem. 2024 Jun 27;276:116625.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4